Wednesday, April 28, 2021

Six In The Morning Wednesday 28 April 2021

 

Serum Institute of India cuts Covishield vaccine price for States to ₹300 per dose

Shoumojit Banerjee



With a number of States expressing their inability to commence the third phase of vaccination from May 1 owing to vaccine paucity, the Pune-based Serum Institute of India (SII) on Wednesday announced that it was reducing the price of its ‘Covishield’ vaccine to the States from ₹400 to ₹300 per dose as a “philanthropic gesture”. 

“As a philanthropic gesture on behalf of SII, I hereby reduce the price to the states from ₹400 to ₹300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives,” said SII CEO Adar Poonawalla on Twitter. 

SII had earlier given its per dose pricing of its ‘Covishield’ vaccine as ₹150 for the Central government, ₹400 for State governments and ₹600 for private hospitals while Bharat Biotech (which rolls out ‘Covaxin’) had quoted ₹150 for the Centre, ₹600 for State governments ₹1200 for private hospitals.  


Hong Kong passes law that can stop people leaving

Bar association and activists decry Beijing-type immigration act with ‘exit ban’ powers

Agence France-Presse in Hong Kong

No comments:

Translate